Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older
Hector S. Izurieta; Michael Wernecke; Jeffrey Kelman; Sarah Wong; Richard Forshee; Douglas Pratt; Yun Lu; Qin Sun; Christopher Jankosky; Philip Krause; Chris Worrall; Tom MaCurdy; Rafael Harpaz
Author Information: Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.